ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

Benacerraf Named Farber President

February 8, 1980

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

Home Test Detects Hematuria Earlier

August 4, 1989

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985